Summary: EMIT assays for the determination of phenytoin, methotrexate, disopyramide, digoxin and thyroxine were adapted to the Cobas Bio centrifugal analyzer and compared with the corresponding laboratory routine procedures. Evaluation of the data from the Cobas Bio by 5 different mathematical models showed that the fourparameter logit model correlated best with the comparison procedures and the originally recommended calculation model for the reagent lots used in our study. The precision of the EMIT phenytoin, methotrexate and disopyramide assays was in most cases very good\(between-days coefficients of Variation^ l .6-7.5%). A lower precision was observed with the EMIT digoxin assay (between-days coefficient of Variation 9.2-16.8%) and at low concentrations also with the EMIT thyroxine assay (3.1-21.4%). Calibration curves of the EMIT phenytoin and methotrexate assays were stable for at least one hour. The results from the determination of phenytoin, methotrexate and disopyramide in patient sainples by use of the Cobas Bio were in good agreement with those values obtained with the EMIT/LAB. The data determined with the EMIT digoxin assay adapted to the Cobas Bio correlated better with those of a radioimmunoassäy than the values measured with the EMIT/LAB System. The results of thyroxine determinations with EMIT by use of the Cobas Bio and the original procedure with an AB A-100 were in good agreement and on average aboüt 12% lower than those measured by radioimmunoassäy. The Cobas Bio allows rapid determinations with EMIT and a reduction in direct costs of ujHo 85%. 
Introduction
A far . reaching mec hanization of the EMIT appears In recent years the Enzyme Multiplied Immunoassay to be necessaiy in order to achieve high reliability and Technique (EMIT®) has been adapted to a great number good practicability with these assays. Furthermore of partially and fully mechanized analytical Systems (1) . the costs for reagents and technician time can be con-0340-076X/82/0020-0765$02.00 © by Walter de Gruyter & Co, · Berlin · New York siderably reduced if suitable mechanization is chosen. In the present study we report on an evaluation of various EMIT assays adapted to the Cobas Bio centrifugal analyzer.
Materials and Methods

Enzyme immunoassay (EMIT)
The reagents for the enzyme immunoassay (EMIT) were obtained from E. Merck (D-6100 Darmstadt):
Meickotest® The EMIT was mechanized by use of a <Cobas> Bio centrifugal analyzer according to the instructions of the manufacturer of this analytical System (F. Hoffman-La R che AG, Diagnostica, CH-4002 Basel). · . \ In addition, the EMIT phenytoin, methotrexate, disopyramide, and digoxin assays were performed by the original prpcedures using an EMIT/LAB System, and thyroxine was determined with EMIT by use of an ABA-100. Furthermoie phenytoin and methotrexate determinations were perfonned by EMIT with an Eppendorf analyzer 5010 (2, 3). Model 5: spline approximati n c = ai + bi (R -RO + q (R -Ri) ? + di (R ^ Rj) 3 with a set of parameters aj, bj, q, and dj for each interval between the rates for two successive Standards R| and
Where: R = rate of change of absorbance C = concentration of the Standards R 0 = the predicted rate for a Standard with zero concentration K c = the predicted difference between R m , the rate of absorbance change for a Standard with infinite concentration, and RO K = a scale parameter for model 3 a, b, c, d = various parameters which define the non-linear elements of each model Radioimmunoassay Digoxin determinations were carried out by radioimmunoassay using coated tubes (Becton-Dickinson, D-6900 Heidelberg), according to the instructions of the manufacturer. Thyroxine was measured by radioimmunoassay s previously described (4).
Evaluation of the results by mathematical models
For the evaluation of the results obtained by EMIT with the (Cobas) Bio five mathematical models (5, 6) were used:
Results
Precision
The EMIT phenytoin assay yield_ed between-days ccê fficients of Variation of 2.2-5.3%, if the actu l calibration curve of each run was used and of 3.9-7.0% with a fixed calibration curve (figil). The deviation of means from target values of the corresponding control The use of the first calibration curve of each day instead of an actual calibration curve yielded similar resuits with a slightly higher coefficient of Variation of 6.9%. Again no distinct differences in precision were observed with the mathematical models tested.
With the EMIT disopyramide assay between-days coefficients of Variation ranged from 1.6-3.8% (accompanying calibration curves) and from 6.3-8.1% (fixed calibration curves). The means showed only minor deviations from the target values (up to 6%) with accompanying calibration curves, and strong deviations (up to 24%) with fixed calibration curves ( fig. 3 ).
Between-days coefficients of Variation ranged with the EMIT Digoxin manual assay from 9.2-16.8% and with the EMITt® Thyroxine test from 3.1-21.4% (figs. 4 and 5).
In all of these assays the precisibn was almost equal whicheVer mathematical model was used for the evaluation of the results. From our experience it seems inadvisable to use a fixed calibration curve over a period of several days. Perhaps better calibration curves for this purpose can be obtained if the data of several calibration curves of the s me lot are averaged. Within the same working day the stability of the calibration curves of the EMIT phenytoin and methotrexate assays was sufficient for at least one hour.
Method comparison
Several patieiits' sera were analyzed with the <Cobas> Bio and the EMIT/LAB or other Systems available in the l boratory. The data from the (Cobas) Bio were evaluated by 5 different mathematical models to find out which one correlated best with the comparison pro- T i ι (5) Bio lie in between those measured with both other pro* cedüres. These differences are statistically significant (paired t-test).
In this example Sy was lowest with the evaluation method 4, however, from the s y .x values no distinct preference can be derived. The mean value was highest with method l which* therefore, may agree best with the EMIT/LAB System. 
Practicability and Costs
The (Cobas) Bio centrifugal analyzer appears to be very well suited for the EMIT· "Ehe System shows a high flexibility and allows rapid drug determinations. "A single phenytoiii determination for example takes about 5 minutes. Within one run about 10 patient samples can be analyzed in duplicate.
The costs for reagents and technician time for the (Cobas) Bio are significantly lower than for the original proeedure (EMIT/LAB) or determinations with the Eppendorf analyzer 5010 (Tables 6, 7 ). Using the (Cobas) Bio the costs for a phenytoin determination, for example, can be reduced by about 60-70% and those for a digoxin determination even by 85% (tabs. 6, 7).
In a recent study (10) the re gent consumption was further minimized by use of the Cobas Bio, so that 600 EMIT theophylline assays per kit were possible while maintaining both acceptable precision and accuracy.
Discussion
Compared with other analy cal Systems the (Cobas) Bio in particular shows a high flexibility which facilitates the adaptation of EMIT assays.
In most cases a very good between^days precision was observed with the EMIT phenytoin, methotrexate and disQpyramide assays ( figs. 1-3) . However, the EMIT digoxin assay and, at low concentrations (3.1 Mg/dl), the EMIT thyroxine assay (figs. [4] [5] , showed a some- what lower precision with the (Cobas) Bio than has been reported for other Systems and possibly other reagent lots (l, 4, 7, 8) . Calibration curves of the EMIT phenytoin and methotrexate assays were stable for a period of at least one hour.
The results of the EMIT digoxin assay determined by the <Cobas> Bio correlated better with those of a radioî mmunoassay than the values obtained by EMIT with the EMIT/LAB System (tab. 4). Deviations of more than 30% between the results of EMIT and radioimrnunoassay occurred by use of the EMIT/LAB System in 7 and with the (Cobas) Bio only in 3 out of the same 50 patient samples. In all of these discrepant cases the values measured by EMIT were higher than those obtained by radioirnmunoassay. The lower incidence of possible interferences with the EMIT digoxin assay adapted tö the (Cobas) Bio may be due to the higher dilution of the sample in the reaction medium. Further* more the results of the EMIT thyroxine assay determined by the (Cobas) Bio and the original procedure with an AB A4 00 were in good agreerrient (tab. 5).. The thyroxine values obtained by EMIT were on average abput 12% lower than those measured by fadiö-immunöassäy. Corriparing the EMIT thyroxine assay with radioimmunoassay (tab. 5), the Standard error of the residuals was lower witii the (Cobas) Bio than with the ABA-100.
In comparisön with the original EMIT teehfiique the best mathematical method for the evaluation of the results appeared to be model l. In addition model 4 yielded very good results for thyröxine. Sitice rriost EMIT procedüres apply a four or five parameter logit model it is not surprising that evaluation by model l provided a better cofrelation than model 5 (spline approximation). This conclusion is based on the reagent lots used duririg this study. In summary it is conclüded that the (Cobas) Bio is very well suited fpr Üie mechanization of the EMIT, äs it allows rapid, reliäble determinations with this techriiqüe and a considerable reduction in direct costs.
